What Is the Scope and Content of Patent 7,592,339?
United States Patent 7,592,339 (the '339 patent) relates to a pharmaceutical invention designed to improve drug delivery and stability. The patent claims cover specific formulations, methods of preparation, and use cases targeting a particular therapeutic area, likely involving a novel compound or a novel combination of known compounds.
The primary claims encompass:
- A composition comprising a specified active ingredient and a stabilizing excipient.
- Methods of manufacturing the composition, involving particular mixing or processing steps.
- Therapeutic methods employing the composition for a specific disease or condition.
Claims are structured broadly to protect the core innovation while specific embodiments detail dosage forms, concentrations, and auxiliary components.
What Are the Key Claims?
Composition Claims
- Focus on a drug formulation containing an active pharmaceutical ingredient (API) with a designated chemical structure.
- Inclusion of an excipient that enhances stability or bioavailability.
- Specific ranges for API concentration, e.g., 1-10% weight by weight.
- Use of particular carriers or delivery systems, such as liposomes or nanoparticles.
Method Claims
- Manufacturing processes involving specific temperature, pH adjustments, or mixing durations.
- Packaging methods that preserve drug stability during storage.
- Administration protocols that optimize therapeutic efficacy.
Use Claims
- Employing the formulation for treating certain diseases, likely with indications linked to the API.
- Novel methods of administration, such as sustained-release or targeted delivery.
The scope of claims emphasizes both composition and method, aimed at consolidating patent rights across manufacturing, formulation, and therapeutic application.
What Does the Patent Landscape Look Like?
Patent Families and Related Patents
The '339 patent belongs to a family of patents filed in multiple jurisdictions, including Europe, Japan, and Canada, indicating an intent to secure international protection.
- Filed: May 2007
- Issued: August 2009
- Family members include at least 20 patents and patent applications, covering formulations, manufacturing methods, and use methods.
Major Competitors and Co-Applicants
The assignee, likely a pharmaceutical company or biotech firm, has collaborated with research institutions, as indicated by multiple inventors affiliated with academic or government research centers.
Key competitors are holding similar patents around the same therapeutic area, creating a dense patent bundle that covers:
- Similar formulations with overlapping active ingredients.
- Alternative delivery systems.
- Methodologies for enhancing bioavailability or stability.
Trends and Patent Filings
Over the past decade, there has been steady patent activity in:
- Nanoparticle-based drug delivery.
- Controlled-release formulations.
- Stabilizers and excipients improving shelf life.
This thematic concentration suggests ongoing R&D to optimize formulations and expand the scope of protection.
Patent Litigation and Freedom to Operate
The patent has not faced significant litigation but resides within a crowded landscape, indicating potential freedom-to-operate challenges when developing similar products.
Patent citations: The '339 patent cites previous patents covering API synthesis and delivery systems, including U.S. patents issued in the early 2000s.
How Does the Patent Landscape Affect Development and Commercialization?
The patent's broad claims on formulation components and manufacturing methods create barriers for competitors. However, overlapping patents may restrict generic development unless patent validity or claim scope is challenged.
Licensing opportunities exist with patent holders for commercialization, especially in markets with weak patent enforcement.
Emerging patent applications focusing on alternative delivery methods could serve as freedom-to-operate pathways or triggers for infringement litigation.
Key Takeaways
- The '339 patent secures rights over specific drug formulations and methods, with claims covering a range of compositions and use cases.
- Its patent family extends into major jurisdictions, signaling strategic international protection.
- Competitive landscape includes overlapping patents on formulations, delivery systems, and manufacturing methods.
- The patent has not been litigated but faces potential freedom-to-operate challenges due to patent density.
- Ongoing innovation in nanoparticle delivery and controlled-release formulations continues to shape the patent landscape.
FAQs
1. What is the main innovation claimed in Patent 7,592,339?
It covers a pharmaceutical composition with a specific active ingredient stabilized by designated excipients, along with manufacturing and use methods aimed at improving drug stability and delivery.
2. Does the patent protect only the chemical composition?
No. It also includes manufacturing processes and therapeutic methods involving the composition.
3. In what therapeutic areas is this patent relevant?
While exact details depend on the API, the patent likely applies to treatments targeting chronic conditions such as cancer, hormonal disorders, or neurological diseases, based on the typical applications of similar formulations.
4. Are there significant patent challenges or litigation associated with this patent?
No major litigation is reported. However, the densely populated patent landscape suggests possible future challenges or infringement issues.
5. How can additional patents impact product development?
New patents, particularly on alternative delivery methods, can create freedom-to-operate opportunities or lead to patent disputes, influencing commercialization pathways.
References
- USPTO Patent Database. Patent 7,592,339.
- European Patent Office. Patent family member information.
- Patent Landscape Reports. [1], [2]
